Colorectal Cancer Clinical Trials in Boston, MA

Colorectal Cancer Clinical Trials in Boston, MA

View the best 10 colorectal cancer medical studies in Boston, Massachusetts. Access promising new therapies by applying to a Boston-based Colorectal Cancer clinical trial.

Top rated colorectal cancer clinical trials in Boston, Massachusetts

Here are the top 10 medical studies for colorectal cancer in Boston, Massachusetts

Image of Massachusetts general Hospital in Boston, United States.

Nivolumab +1 More

Checkpoint Inhibitor

Recruiting2 awardsPhase 2
This trial is studying a combination of drugs as a possible treatment for certain types of cancer. The drugs are Nivolumab and Ipilimumab, and the radiation therapy is meant to target the cancer specifically.
Image of Call for Information (Investigational Site 0202) in Los Angeles, United States.

Pembrolizumab

PD-1 Inhibitor

Recruiting1 awardPhase 2
This trial is testing a new immunotherapy drug for people with advanced cancer who have progressed on standard of care therapy.
Image of Moffitt Cancer Center-International Plaza in Tampa, United States.

Pembrolizumab +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 1
This trial is testing ziv-aflibercept given with pembrolizumab to see if it is safe and effective in treating patients with advanced solid tumors.
Image of Massachusetts General Hospital in Boston, United States.

TAS-102

Nucleoside analog

Recruiting2 awardsPhase 1 & 2
This trial is studying how well TAS-102 and radiation therapy work in treating patients with hepatic metastases from colorectal cancer.
Image of Codman Square Health Center in Boston, United States.

Introduction of Implementation Strategies

Recruiting1 award2 criteria
This trial will use a combination of focus groups and data analysis to examine how well a new population management platform works in primary care clinics.
Image of VA Boston Healthcare System in Boston, United States.

Polygenic risk score (PRS)

Polygenic Risk Score

Recruiting1 award1 criteria
This trial will test how well polygenic risk score testing works in patients who are at high genetic risk for certain diseases.
Image of CTCA at Western Regional Medical Center in Goodyear, United States.

Trastuzumab +3 More

Monoclonal Antibodies

Recruiting1 awardPhase 2
This trial studies trastuzumab and pertuzumab compared to cetuximab and irinotecan hydrochloride in treating patients with HER2/neu amplified colorectal cancer.
Image of Kaiser Permanente in Los Angeles, United States.

Transanal Total Mesorectal Excision (taTME)

Procedure

Recruiting1 award10 criteria
This trial is a phase II multicenter single-arm study to evaluate the safety and efficacy of low anterior resection (LAR) with taTME using laparoscopic or robotic assistance in 100 eligible subjects with resectable rectal cancer.
Image of City of Hope (City of Hope National Medical Center, City of Hope Medical Center) in Duarte, United States.

Encorafenib +1 More

Kinase Inhibitor

Recruiting2 awardsPhase 3
This trial is testing a new combination of drugs to treat colorectal cancer that has spread and has a certain type of abnormal gene. The new combination is encorafenib plus cetuximab, which will be taken either alone or with standard chemotherapy.
Image of Research Site in Duarte, United States.

AZD9592

Recruiting1 awardPhase 1
This trial evaluates the safety and effectiveness of AZD9592 to treat advanced solid tumors. It looks at how it works, how it affects the body, and potential side effects.

Popular filter options for colorectal-cancer boston trials

Phase 3 Clinical Trials

View 97 phase 3 medical studies.

Clinical Trials With No Placebo

View 97 medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.